{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:17:11Z","timestamp":1791051431821,"version":"4.1.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Globally, primary liver cancer (PLC) ranks the most fatal malignancy. Most of the patients are in advanced stage of PLC at the very time they are diagnosed with it, accounting much for its poor prognosis. With the advancement of modern medical research and care system, the main etiology of PLC more and more switches from hepatitis viruses such as HAV, HBV, HCV, HEV to other causes like metabolism-associated steatohepatitis (MASH) and metabolic-associated fatty liver disease (MAFLD). As a result, it is of great necessity to find out new ways for treatment and early diagnosis to cope with this problem. Nowadays, as the mechanism of the Gut-Liver Axis in the formation of MAFLD, MASH and PLC has been gradually elucidated. The association between gut microbiome and the formation of PLC is of great significance to take an insight into. In this review, we present the concept of Gut-Liver Axis and its function in the mutual influence between gut microbiota and PLC from several aspects in which we will focus on the structure of gut barrier and the functional influences the gut microbiota have on the immune response and metabolic changes on human liver. Furthermore, we conclude the potential association of gut microbiota constitution with the PLC. Eventually, we hope this review can offer novel instructions for early diagnosis and treatment for liver cancer.<\/jats:p>","DOI":"10.3389\/fcimb.2025.1467197","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:43:33Z","timestamp":1738046613000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights"],"prefix":"10.3389","volume":"15","author":[{"given":"Xuran","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runqiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","article-title":"Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg","volume":"12","author":"Arab","year":"2018","journal-title":"Hepatol. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"8507583","DOI":"10.1155\/2019\/8507583","article-title":"Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease","author":"Aragones","year":"2019","journal-title":"BioMed. Res. Int 2019"},{"key":"B3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","volume":"307","author":"B\u00e4ckhed","year":"2005","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.molmed.2021.06.007","article-title":"The gut vascular barrier: a new player in the gut-liver-brain axis","volume":"27","author":"Brescia","year":"2021","journal-title":"Trends Mol. Med."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203894119","article-title":"Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.livres.2017.11.005","article-title":"Gut microbiota, fatty liver disease, and hepatocellular carcinoma","volume":"2","author":"Chu","year":"2018","journal-title":"Liver Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2019.09.014","article-title":"Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity","volume":"51","author":"Chun","year":"2019","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.3.1031","article-title":"Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides","volume":"81","author":"Clifton","year":"2001","journal-title":"Physiol. Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.apsb.2019.12.001","article-title":"The gut microbiome: an orchestrator of xenobiotic metabolism","volume":"10","author":"Collins","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"B12","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","article-title":"Pleiotropic roles of bile acids in metabolism","volume":"17","author":"de Aguiar Vallim","year":"2013","journal-title":"Cell Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"den Besten","year":"2013","journal-title":"J. Lipid Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"100032","DOI":"10.1016\/j.xinn.2020.100032","article-title":"Therapy of Primary Liver Cancer","volume":"1","author":"Feng","year":"2020","journal-title":"Innovation (Camb)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"B17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1172\/JCI83885","article-title":"Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9","volume":"126","author":"Garcia-Martinez","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"G1168","DOI":"10.1152\/ajpgi.00219.2004","article-title":"Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose","volume":"287","author":"Gaudier","year":"2004","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jcmgh.2021.02.007","article-title":"Regulation of Intestinal Barrier Function by Microbial Metabolites","volume":"11","author":"Ghosh","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.transproceed.2016.01.077","article-title":"Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis","volume":"48","author":"Grat","year":"2016","journal-title":"Transplant. Proc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1096\/fj.09-141929","article-title":"Tlr2 is critical for diet-induced metabolic syndrome in a murine model","volume":"24","author":"Himes","year":"2010","journal-title":"FASEB J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.32449","article-title":"Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC","volume":"77","author":"Hu","year":"2023","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41586-024-08135-z","article-title":"Colibactin-driven colon cancer requires adhesin-mediated epithelial binding","volume":"635","author":"Jans","year":"2024","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.12938\/bmfh.18-032","article-title":"The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms","volume":"38","author":"Jasirwan","year":"2019","journal-title":"Bioscience Microbiota Food Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2020.05.001","article-title":"Personalized mapping of drug metabolism by the human gut microbiome","volume":"181","author":"Javdan","year":"2020","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s13238-020-00748-0","article-title":"Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma","volume":"12","author":"Jia","year":"2021","journal-title":"Protein Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.peptides.2013.10.008","article-title":"Differential regulation of human cathelicidin LL-37 by free fatty acids and their analogs","volume":"50","author":"Jiang","year":"2013","journal-title":"Peptides"},{"key":"B30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1741-7015-10-98","article-title":"Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide","volume":"10","author":"Jing","year":"2012","journal-title":"BMC Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41467-021-21461-4","article-title":"Fructose reprogrammes glutamine-dependent oxidative metabolism to support LPS-induced inflammation","volume":"12","author":"Jones","year":"2021","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/hep.32705","article-title":"Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression","volume":"77","author":"Juarez-Fernandez","year":"2023","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1124\/dmd.117.077222","article-title":"Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice","volume":"46","author":"Kim","year":"2018","journal-title":"Drug Metab. Dispos"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.4254\/wjh.v8.i32.1354","article-title":"Toll-like receptors in pathophysiology of liver diseases","volume":"8","author":"Kiziltas","year":"2016","journal-title":"World J. Hepatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nat. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12986-018-0319-2","article-title":"Trimethylamine N-oxide, a gut microbiota-dependent metabolite of choline, is positively associated with the risk of primary liver cancer: a case-control study","volume":"15","author":"Liu","year":"2018","journal-title":"Nutr. Metab. (Lond)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","article-title":"Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE(2)-Mediated Suppression of Antitumor Immunity","volume":"7","author":"Loo","year":"2017","journal-title":"Cancer Discovery"},{"key":"B38","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/eji.201646799","article-title":"Human beta-defensin 3 increases the TLR9-dependent response to bacterial DNA","volume":"47","author":"McGlasson","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/hep.26081","article-title":"Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice","volume":"57","author":"Miura","year":"2013","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.3748\/wjg.v20.i23.7381","article-title":"Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease","volume":"20","author":"Miura","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J. Hepatol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01458","article-title":"Analysis of the Relationship Between the Degree of Dysbiosis in Gut Microbiota and Prognosis at Different Stages of Primary Hepatocellular Carcinoma","volume":"10","author":"Ni","year":"2019","journal-title":"Front. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","article-title":"The intestinal epithelial barrier: a therapeutic target","volume":"14","author":"Odenwald","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/cphy.c170050","article-title":"Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology","volume":"8","author":"Priyadarshini","year":"2018","journal-title":"Compr. Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","article-title":"Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma","volume":"68","author":"Ren","year":"2019","journal-title":"Gut"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.3389\/fphys.2018.01908","article-title":"Regulation of Adaptive Thermogenesis and Browning by Prebiotics and Postbiotics","volume":"9","author":"Reynes","year":"2018","journal-title":"Front. Physiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"106348","DOI":"10.1016\/j.phrs.2022.106348","article-title":"Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury","volume":"182","author":"Rodriguez-Diaz","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cphy.c130024","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.cmet.2020.03.006","article-title":"Gut-Resident Lactobacilli Activate Hepatic Nrf2 and Protect Against Oxidative Liver Injury","volume":"31","author":"Saeedi","year":"2020","journal-title":"Cell Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1038\/s41467-022-31312-5","article-title":"Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment","volume":"13","author":"Schneider","year":"2022","journal-title":"Nat. Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","article-title":"The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages","volume":"50","author":"Schulthess","year":"2019","journal-title":"Immunity"},{"key":"B54","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut Microbiota in Health and Disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol. Rev."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00025","article-title":"The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2018.09.004","article-title":"Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer","volume":"175","author":"Singh","year":"2018","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.chom.2013.08.008","article-title":"Finding a sugary foothold: how antibiotics pave the way for enteric pathogens","volume":"14","author":"Stecher","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/nu9101072","article-title":"Animal Models of Nonalcoholic Fatty Liver Disease-A Starter\u2019s Guide","volume":"9","author":"Van Herck","year":"2017","journal-title":"Nutrients"},{"key":"B59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab."},{"key":"B60","doi-asserted-by":"publisher","first-page":"52:1442","DOI":"10.1136\/gut.52.10.1442","article-title":"Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E1 and E2 production by intestinal myofibroblasts","volume":"2003","author":"Willemsen","year":"2003","journal-title":"Gut"},{"key":"B61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","article-title":"Linking long-term dietary patterns with gut microbial enterotypes","volume":"334","author":"Wu","year":"2011","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jhep.2022.12.028","article-title":"Gut microbiota promote liver regeneration through hepatic membrane phospholipid biosynthesis","volume":"78","author":"Yin","year":"2023","journal-title":"J. Hepatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/hep.23845","article-title":"Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents","volume":"52","author":"Yu","year":"2010","journal-title":"Hepatology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrgastro.2017.72","article-title":"The gut microbiome and liver cancer: mechanisms and clinical translation","volume":"14","author":"Yu","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.hbpd.2019.01.002","article-title":"Relationship between intestinal microbial dysbiosis and primary liver cancer","volume":"18","author":"Zhang","year":"2019","journal-title":"Hepatobiliary Pancreat Dis. Int."},{"key":"B67","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"B68","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/mi.2017.118","article-title":"GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3","volume":"11","author":"Zhao","year":"2018","journal-title":"Mucosal Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1002\/cam4.v9.12","article-title":"Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma","volume":"9","author":"Zheng","year":"2020","journal-title":"Cancer Med."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1467197\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:43:36Z","timestamp":1738046616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1467197\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":69,"alternative-id":["10.3389\/fcimb.2025.1467197"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1467197","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"article-number":"1467197"}}